Saturday, September 7, 2024
9/7/2024
PROJECT SUMMARY Aged individuals, who are often at higher risk of fatality in life-threatening infectious diseases, do not form high- quality antibodies against new infections. Humoral immunity against infections depends on the germinal center (GC) differentiation process in the B cell follicles of lymph nodes. In GCs, naïve B cells rapidly proliferate in response to T cell-dependent antigens and somatically mutate into high-affinity antibody-secreting cells, i.e., plasma cells. A significant concern is that with aging, B cells exhibit a decreased expansion of B cells and GC reaction in response to antigen. However, it is unclear whether this is solely due to immune senescence and a defect in B cells or the follicular T helper cell (TFH), and whether the lymphoid microenvironment of B cell follicles plays a role. B cells in young mice assume heterogeneous cell fates upon stimulation, with only a fraction differentiating into antibody-secreting cells (ASC), however, this phenomenon remains unknown in B cells from old mice. Notably, plasma cell differentiation in young B cells is controlled by multiple cell division-coupled epigenetic programs, which also remains understudied in old B cells. Because aged mice cannot generate sufficient GCs to provide insight into ASC fate and epigenomic remodeling of GC B cells, necessitating the development of a tissue-engineered model of aged lymphoid tissues. The long-term goals of this R01 are 1) to develop an ex vivo “aged B cell follicle” organoid technology capable of providing lymphoid microenvironment signals in a plug-and-play manner to induce early GC programming of aged B cells from mice and human B cells, therefore enabling the study of plasma cell fate and regulation of the epigenome of B cells; and 2) to identify checkpoint targets that can be suppressed to boost GC response in aged B cells. PI has demonstrated that GCs phenotype could be generated in organoids using B cells from >2-yr old mice when differentiated under young lymphoid microenvironment conditions, however to a lesser extent than young B cells. However, true differentiation fate of aged B cells ex vivo can only be realized in a microenvironment representative of old lymph nodes.The R01 is highly significant and innovative because it will 1) establish lymphoid microenvironment of aged lymph nodes and engineer a hydrogel-based “aged” immune organoid to study vaccine and infection responses, 2) enable control over the ex vivo B cell differentiation of aged B cells in ex vivo cultures and generate antigen-specific antibodies against infections, 3) define the cell division kinetics of B cell differentiation and identify the molecular and epigenetic trajectories of aged B cell fate and ASC formation, and 4) identify checkpoint targets to accelerate GCs in aging.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
